Hadasit Bio-Holdings

Press Releases

Results of a Public Offering According to its Shelf Offer Report from December 16, 2015

Dec. 20, 2015

HBL Hadasit Bio-Holdings Ltd.

("the Company")

 

 

To:

 

To:

The Israel Securities Authority

 

The Tel Aviv Stock Exchange Ltd.

www.isa.gov.il

 

www.tase.co.il

December 20, 2015

Re: An Immediate Report Concerning the Results of a Public Offering According to its Shelf Offer Report from December 16, 2015

Pursuant to Section 30 of the Securities Law, 5728-1968, and the Securities Regulations (Notice of Results of the Offer in a Prospectus), 5729-1969, the Company hereby respectfully announces the results of a public offering according to shelf offer report the Company published on December 16, 2015 (hereinafter: "the Shelf Offer Report"), according to the Company's shelf prospectus from October 26, 2015 (reference number: 2015-01-141126).

1.                  According to the Shelf Offer Report, the Company offered the public up to 23,000,000 common Company shares, listed by name, with a nominal value of NIS 0.05 each, of the Company, and up to 26,450,000 common Company shares if there was an additional offering, as defined in Section 5 of the Shelf Offer Report.

2.                  The securities were offered to the public, through a uniform offering pursuant to the Securities Regulations (Method of Offering Securities to the Public) 5767-2007, in 23,000 units (hereinafter: "the Unit" or "the Units"), by means of a tender for the Unit price (hereinafter: "the Tender"), where the minimum Unit price was NIS 340 (hereinafter: "the Minimum Unit Price"), and the composition of each Unit was as follows:

Number of securities in the Unit

Minimum price for the security

Total

1,000 common shares

NIS 0.34 per share

NIS 340

The Minimum Unit Price

 

NIS 340

3.                  The period for submitting orders for the purchase of the Units was opened on December 17, 2015, at 9:00 and closed on the same day at 16:30.

4.                  The following are the results of the public offering according to the Shelf Offer Report:

4.1.            Within the framework of the tender, a total of 12 orders were received for the purchase of 30,462 Units, totaling NIS 11,335 thousand, from which a total of 2 orders were received for the purchase of 17,792 Units, totaling NIS 6,325 thousand, from the Company's stakeholders.

4.2.            The Unit price set in the tender is NIS 360 (hereinafter: "the Set Unit Price").

4.3.            The total amount of allocated Units is 24,934, of which 1,934 were allocated in an additional allocation pursuant to the provisions of Section 5 of the Shelf Offer Report.

4.4.            The allocation of the Units in the tender (including the additional allocation) was carried out pursuant to the provisions of the Shelf Offer Report as follows:

4.4.1.          4 orders for the purchase of 10,190 Units, that were priced higher that the Set Unit Price, were fully met.

4.4.2.          4 orders for the purchase of 14,744 Units, that were priced at the Set Unit Price, were fully met.

4.4.3.          4 orders for the purchase of 5,528 Units, that were priced lower than the Set Unit Price, were not met.

5.                  A total of 13,800 Units were allocated, totaling NIS 4,968 thousand, to the Company stakeholders.

6.                  The gross consideration received by the Company from the allocation of securities that were offered to the public according to the Shelf Offer Report is NIS 8,976,240 thousand.

7.                  The offer of the Units was not assured by underwriting.

 

The Company thanks the investors for their response to the offer.

Sincerely,

HBL Hadasit Bio-Holdings Ltd.

    By: Ms. Tamar Kfir, CEO

 
 

Press Releases Archive